Clinical Trials And Corruption Risks

by Michael Volkov

clinical4Pharmaceutical and medical device companies have enough to worry about when it comes to enforcement risks.  It is only in the last ten years that FCPA enforcement has been added to their list of worries.

With the increase in FCPA enforcement, pharmaceutical and medical device companies have to worry about a number of interactions between their staff and foreign doctors, and foreign healthcare officials.  Drug and device companies have to monitor a number of interactions, including clinical trials, travel sponsorships, consulting arrangements, medical device equipment trials and other types of interactions.

Clinical trials are a particular risky area.  Pharmaceutical and medical device companies often enlist foreign doctors and medical institutions to conduct, or assist in conducting, clinical trials.  These foreign healthcare providers are all deemed “foreign officials” under the FCPA.

Clinical research can be designed: (1) to generate the clinical data required in order to obtain FDA approval; or (2) to generate clinical data about an FDA approved product in order to develop marketing programs.  Clinical trials are risky enough but when you add a layer of FCPA risks and compliance, you have a recipe for disaster.clinical5

Drug and device companies have steadily been increasing the number of foreign clinical trials.  The primary motivation for moving clinical trials overseas is to save on costs.   Almost 75 percent of clinical trials investigating FDA-regulated products are conducted in foreign countries.  Approximately 80 percent of the participants in all clinical trials were enrolled at foreign locations.

In many cases, drug and device companies contract with Clinical Research Organizations (CROs), academic and health care facilities, and foreign physician investigators.  CROs are used to manage clinical trials with foreign medical institutions, and act like a third-party agent for a company and interact directly with foreign physicians and medical institutions.

Companies using CROs have to conduct due diligence review of the CROs like any third-party agent and negotiate appropriate contractual provisions to minimize foreign bribery risks.  The Department of Justice and SEC have focused on the significant risk that companies may pay bribes to foreign physicians and healthcare officials to generate favorable clinical data.  Such bribery can mask serious health risks to ultimate consumers.

clinical3Some companies retain foreign physicians to assist a clinical trial as individual investigators.  Prosecutors are suspicious of such arrangements since they fear that the individual physicians will attempt to “influence” the clinical trial contrary to an objective scientific analysis.

Drug and device companies will continue to conduct clinical trials in foreign locations.  The economics and regulatory environment is favorable.  As a result, compliance officers face a real challenge in navigating these risks.  Compliance officers have to design and implement a robust compliance program which includes detailed due diligence and internal controls to make sure they do not run afoul of the FCPA.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Michael Volkov, The Volkov Law Group | Attorney Advertising

Written by:

Michael Volkov

The Volkov Law Group on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.